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ABBREVIATION 
AKI   Acute Kidney Injury 
NGAL   Neutrophil gelatinase associated lipocalin 
KDa  Kilo Dalton 
ELISA   Enzyme Linked Immunosorbent Assay 
LDH  Lactate Dehydrogenase 
CaCl2  Calcium chloride 
ATN   Acute Tubular Necrosis 
GFR   Glomerular Filtration Rate 
RVV   Russell’s Viper Venom 
DIC   Disseminated Intravascular coagulation 
aPTT   Activated Partial Thromboplastin Time 
RBCs   Red Blood Cells 
USG   UltraSonoGram 
NaOH  Sodium Hydroxide 
AUC  Area under curve 
ROC   Receiver operating curve 
EDTA   Ethylene diamine tetra acetic acid 
BT   Bleeding Time 
CT                    Clotting Time 
HRP   Horse Radish Peroxidase 
TMB  Tetra Methyl Benzidine 
Conc.   Concentration       
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INTRODUCTION 
 
               Acute kidney injury is a clinical syndrome characterized by  an 
abrupt  decline in Glomerular filtration rate sufficient to decrease their 
elimination of nitrogenous waste products and other uremic toxins from 
the body.1  
 
                Acute kidney injury is seen in majority of the cases of snake bite.  
The gravity, spectrum and the outcome varies. Snake bites cause 
substantial mortality and morbidity in India. 
 
                Snakes are fascinating part of nature. Their colour, movement 
and secret habits make them more mysterious. India is home to some of the 
most poisonous snakes in the world, most of them are found in rural areas. 
A large proportion of snake bites occur when people are working barefoot 
in the field, or while walking at night or early morning through fields or 
along roads.² 
 
              Of 3000 species of snakes known to world,  in India, we have 
around 216 species, out of which 52 are known to be poisonous.³ Majority 
of  bites and consequent mortality is attributable to 5 species viz, 
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Ophiophagus hannah (king cobra), Naja Naja (common cobra), Daboia 
rusellii (Russell’s viper), Bungarus caeruleus (krait) and Echis carinatae 
(saw  scaled viper).³ 
 
               AKI due to snake bite represents a frequent and devastating 
problem, so early diagnosis can prevent morbidity and mortality. AKI is 
usually asymptomatic and diagnosed by biochemical monitoring of 
increase in serum creatinine concentrations.⁴ 
 
               The  rise in serum creatinine is delayed by few days, because the 
serum creatinine concentration does not increase until half of the kidney 
function is lost.⁵  
 
In general, there are several non-renal factors influencing the serum 
creatinine concentration such as body weight, muscle mass, race, age, 
gender, total body volume, drugs, muscle metabolism and protein intake.⁶ 
 
               In the cellular insult like AKI, the injury begins by inducing 
molecular modifications, later evolving into cellular damage. The cells 
start producing marker of injury and the clinical symptoms develops 
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subsequently. Thus the detection of  biomarkers may provide the much 
needed window of opportunity for early intervention. 
 
                Human Neutrophil Gelatinase Associated Lipocalin is 25kDa 
secretory  glycoprotein belongs to the lipocalin family⁷ expressed by 
kidney cells and undergo an early dramatic upregulation in response to 
nephrotoxic injury like snake bite. 
 
                NGAL is easily measured, unaffected by other biological 
variables and capable of  both early detection and risk stratification⁷. 
Hence, it would represent a tremendous advance in clinical medicine. 
NGAL has been found to be very useful for the detection of acute kidney 
injury within 2 hours of  nephrotoxic insult.⁷ 
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AIM OF THE STUDY 
 
1. To estimate  plasma  neutrophil gelatinase-associated lipocalin (NGAL)  
in  patients with snake bite . 
2. To correlate NGAL values with serum creatinine and blood urea  and to  
     prove  the use of  NGAL as  an early biomarker of Acute Kidney Injury 
in patients with  snake bite. 
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REVIEW OF LITERATURE 
 
                Acute Kidney Injury is characterized by deterioration in the 
Glomerular Filtration Rate (GFR) over a period of hours or days resulting 
in accumulation of nitrogenous waste products. 
 
EPIDEMIOLOGY OF VENOMOUS SNAKES AND SNAKE BITE 
INDUCED ACUTE KIDNEY INJURY: 
                 Snake bite poisoning is a preventable health hazard in tropics. 
Very extensive toxicological research is still going on because of high 
incidence. It accounts for 100-150 deaths per day in India and the annual 
deaths per year is around 30,000.3 It is a cause of major preventable death. 
In India, the highest incidence are seen in Tamil Nadu, West Bengal, 
Maharastra, Uttar Pradesh and Kerala.8 
 
               Snake bites happen when the farmers work in field bare footed, 
unintentionally in a handful of foliage, rolling over the snake while asleep, 
while working in other plantation and in snake handling⁹. Males are bitten 
most often than females⁹ with majority of bite being on the lower 
extremities.10 
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             Majority of victim are treated initially by traditional snake bite 
healers. Death often occurs even before the patient reaches hospital¹¹. The 
use of protective foot wear, long trousers and lighting at night could reduce 
the incidence of snake bites.¹² 
 
             Poisonous snakes prevalent in India belong to 3 families¹³.  
They are: 
1) Elapidae: includes Cobras and Krait- Neurotoxic. Renal 
involvement is less common in victims bitten from members of 
this family. 
2) Viperidae: Russell viper and saw scaled viper- Vasculotoxic. 
3) Hydrophidae: Sea snake - Myotoxic. 
    Renal involvement has been associated with bites from 
Viperidae18 and sea snake.14, 15 
 
COBRAS:   
      The two species of Cobras found in India16 are Common Cobra 
(Nalla Pambu) and King Cobra (Raja Nagam, Karu Nagam).17 The Cobra  
has hood which is on the dorsal side often bears a double or single 
spectacle mark. It is distributed throughout India. King Cobra is black in 
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colour and has hood, but no mark on it.  They are found in Himalayas, 
Bengal, Assam and Andaman Islands. 
      
  KRAIT: 
           The two species of krait commonly found in India16 are common 
Krait (kattu Viriyan) and Banded Krait (Pattai Kattu Viriyan).17 The 
common krait has steel blue or black with white bars on the back. It is 
distributed throughout India. Banded krait is jet black with yellow 
stripes on its back. They found in Bengal, Assam, Bihar, Orissa, 
Madhya Pradesh, Andhra Pradesh and Uttar Pradesh.17 
 
VIPER: 
         The two species of viper that are commonly found in India 16 are 
Russell’s  viper (Kannadi Viriyan) and saw scale viper (Surruttai 
Viriyan).17  Russell’s  viper has a triangular head with V shaped mark 
pointing forwards. It has a white body with dark semilunar spots. It is 
seen in Maharastra, Punjab, Rajasthan, Tamil Nadu and Andhra 
Pradesh. Saw scaled viper has many white lines on each flank of the 
back, with diamond shaped areas between the two lines. It has white 
mark resembling an arrow over the head. It is seen in hills and plains 
throughout India. 
. 
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SNAKE VENOM: 
 
        The venom is a modified salivary secretion. The normal function 
of snake venom is to immobilize the prey and assist in digestion. The 
toxic component of snake venom is classified into 4 broad categories 
namely enzymes, polypeptides, glycoproteins and compounds of low 
molecular weight. They can also be classified as protein (90-95%) 
and non protein (5-10%) compounds.19 It also contains Clostridia, 
Anaerobes and Gram negative bacilli.  
 
 
 
Snake Fatal Dose for humans 
Average delivered 
dose per bite 
Average Fatal 
Period 
Indian Cobra 12mg 0.2g 8h 
Common 
Krait 6mg 0.22g 18h 
Russell’s 
Viper 15mg 0.15g 3days 
Saw – Scaled 
Viper 8mg 0.13g 41days 
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TABLE : Compounds present in Snake Venom (61) 
 
Enzymes 
 
Phospholipids A2 (Lecithinase), 5' 
nucleotidase, collagenase, L-amino acid 
oxidase, proteinases, hyualuronidase, 
acetylcholine esterase, phospholipids B, 
endopeptidase, Kininogenase, factor X, 
prothrombin activating enzyme. 
 
Non enzyme polypeptides 
 
Polysynaptic (a) neurotoxin (α 
bungarotoxin and cobrotoxin), presynaptic 
(b) neurotoxin (β bungarotoxin, crotoxin, 
and taipoxin) cardiotoxin, crotamine. 
Peptides Pyroglutamyl Peptide 
Nucleosides Adenosine, guanosine, inosine 
Lipids Phospholipids, cholesterol 
Amines Histamine, Serotonin, Spermine 
Metals Copper, Zinc, Sodium, Magnesium 
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ENZYMES: (61) 
SL.NO Enzymes  Bio- chemical Actions 
1 
 
Acetylcholine Esterase Catalysis and Hydrolysis of Acetylcholine 
2 
 
Arginine ester hydrolase Bradykinin release, interference with clotting 
3 Hyaluronidase A Reduction of Collagen Viscosity 
4 Phospholipase A Un coupling of Oxidative phosphorylation 
5 Phospholipase B Hydrolysis of  Lysophosphatides 
6 Phophodiesterase Inhibition of DNA, RNA, Arabinose derivatives 
7 5’ Nucleotidase Specific Hydrolysis of PO4 Monoesterase which links with 5' position of DNA, RNA 
8 L Amino acid Oxidase Catalysis of Amino Acid 
9 Thrombin like enzymes Depression of Fibrinogen levels 
10 Proteolytic enzymes Tissue destruction and bleeding 
11 Collagenases Collagen digestion 
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Arginine Esterase: 
         This enzyme is produced by snakes belonging to Crotalidae and 
viperidae. This enzyme has action similar to thrombin thereby causes 
coagulation and it releases bradykinin. 
 
Phospholipase A: 
           It has a direct lytic effect, hemolytic effect and hydrolysis of 
phospholipids of  RBC membrane, thereby causing sudden fall in Blood 
Pressure.13     
 
Proteinase: 
           Markedly present in Viper, Crotalidae. It causes tissue changes and 
destruction. 
 
Anti coagulant effect: 
           It has anti coagulant effect due to proteolytic disintegration of 
Fibrinogen. 
 
Coagulant effect: 
           It has Coagulant effect by converting Prothrombin into Thrombin. 
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Non Enzymatic Components: 
           Haemorrhagins (HR-I, HR-II) has direct action on endothelium with 
Procoagulant and Anticoagulant effects. It causes rapid haemorrhage into 
visceral organs, vasoconstriction followed by vasodilatation of 
microvessels, haemorrhages into capillary bed and endothelial destruction.5 
 
PATHOGENESIS OF ACUTE KIDNEY INJURY: 
       The factors that contribute AKI are Direct cytotoxicity, Bleeding, 
Hypotension, Circulatory collapse, Intravascular hemolysis, Disseminated 
Intravascular Coagulation and Micro Angiopathic Hemolytic Anemia 
(MAHA).20 
 
Direct Nephrotoxicity: 
        E.carinatus venom 21 and the demonstration of venom antigen in 
human victims of snake bite using Enzyme Linked Immuno Sorbent Assay 
technique have shown that the venom is excreted in the urine.22 Urinary 
beta-N acetylglucosaminidase showed considerable change in patients 
bitten by Russell’s viper, indicating a direct toxic effect of venom on the 
kidney.23 
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          The sub lethal dose of Russell’s viper or E.carinatus venom resulted 
in hemorrhages in the kidneys and mild acute tubular necrosis in 20 % 
within 24 hrs of envenomation. However, lethal dose developed acute 
tubular necrosis and fibrin thrombi in 50-75% of glomeruli.33 
 
          The strongest evidence supporting that direct nephrotoxicity is a 
dose dependent decrease in inulin clearance and an increase in fractional 
excretion of sodium, following Russell’s viper envenomation.24 
 
        Russell's viper venom  administration induces changes in renal plasma 
flow, glomerular filtration rate, filtration fraction and tubular reabsorption 
of sodium are reduced, and fractional excretion of sodium and water 
showed an increase. Both oliguria and a subsequent polyuric phase occurs.  
 
On morphological analysis, the most prominent structural lesions are 
observed in the renal cortex.25,30 Extensive damage and loss of glomerular 
epithelial cells and endothelium are detected with only the basement 
membrane remaining unaffected. Ballooning and even rupture of 
glomerular capillaries could be seen. 
 
        Another prominent feature of RVV action is on renal cortex and other 
renal zones, concerned vessels with muscular walls (arteries, veins, 
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arterioles, venules). The venom lead to complete lysis of vascular smooth 
muscle cells leaving behind only the basement membrane. Varying degrees 
of epithelial injury occurred in all tubular segments. 
 
          RVV induces a complete disintegration of confluent mesangial cell 
layers at lower concentration. However, only extremely high doses of 
RVV lead to microscopically discernible damage.  Thus, a dose dependent 
toxic effect of RVV directes primarily against glomerular and vascular 
structures and on mesangial cells. 
 
     Myoglobinuria, sepsis and hypersensitivity to venomous or anti-
venomous protein also contribute towards renal failure 26. Myoglobinuria 
generally occurs following sea snake envenomation, which results from 
necrosis of striated muscles and muscular paralysis.27 
 
HYPOTENSION: 
         Bleeding either into tissues or externally and loss of plasma into the 
bitten extremity produce hypotension and circulatory collapse. This is 
caused by venom metalloproteinases, that degrade basement membrane 
protein surrounding the vessel wall, leading to loss of integrity.28 
Hypotension is also caused by release of bradykinin.29  
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Additionally, vasodilatation and increased capillary permeability, 
both as a result of direct and indirect effects of venom, can aggravate the 
circulatory disturbances of shock 30.Vipera palestinae venom is thought to 
cause shock by depression of the medullary vasomotor centre³¹.  
 
Bitis arietans causes hypotension by a combination of myocardial 
depression, arteriolar vasodilatation and increased vascular permeability. 
Hypotension and circulatory collapse set in motion a chain of  
hemodynamic disturbances, which  culminate in ischemic AKI. 
 
Intravascular Hemolysis: 
            Intravascular hemolysis plays a role in the pathogenesis of snake 
bite induced AKI 32.  Hemolysis results from the action of phospholipase 
A2  which is present in all snake venoms, and a basic protein called "direct 
lytic factor”, found in elapid venoms.14,33, 34. 
 
            PhospholipaseA2 causes hemolysis by direct hydrolysis of red cell 
membrane phospholipids or causing indirectly via the production of strong 
hemolytic lysolecithin from plasma lecithin. Severe hemolysis are shown 
by increased plasma LDH levels, free hemoglobin and late presence of 
hemolysed red blood cell casts in renal tubules.  
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The renal failure following snake bite should be considered as an 
example of the hemolytic uremic syndrome35. Microangiopathic hemolysis 
as seen in HUS is encountered rarely.  
 
More than 70-80% of patients with snake bite induced renal failure 
have only acute tubular necrosis and do not exhibit the glomerular and 
arteriolar changes characteristically associated  with the hemolytic uremic 
syndrome.36 
 
Disseminated intravascular coagulation: 
         The human hemostatic system is regulated via a number of critical 
interactions involving blood proteins, platelets, endothelial cells, and sub-
endothelial structures.  
 
Snake venom proteins and peptides are known to activate or 
inactivate many of these interactions. Snake venoms from viper families, 
contain many proteins that interact with members of coagulation cascade 
and the fibrinolytic pathway. 
 
          Russell’s viper venom (RVV) contains a factor V activating serine 
proteinase,37 which has been separated from a factor X-activating protein, 
also present in this venom. The enzyme (RVV-V) is a single chain 
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glycoprotein with a molecular weight of 26,100 possessing one 
glycosylation site near the carboxy terminus.  
 
RVV-V cleaves a single bond to convert factor V to factor Va ( the 
activated clotting protein). Russell’s viper venom contains a potent 
activator of human coagulation factor X; this enzyme is designated as 
RVV-X. 38 Factor X activators have been isolated from bathrops atrox and 
several other snake species. Russell’s viper venom activates factor IX by 
cleavage of a single peptide bond resulting in the formation of factor IXa. 
 
There are several different types of prothrombin activators in snake 
venom. The activity of members of group I is not influenced by 
components of prothrombin activator complex (factor Va, CaCl2 and 
phospholipid).39 Ecarin, from E.carinatus venom, is the most well studied 
member of this group.  Group II activators resemble factor Xa and cleave 
both peptide bonds in prothrombin, leading to active 2-chain thrombin. 
Their activity is strongly stimulated by phospholipids and factor Va in the 
presence of CaCl2.   
 
 
By contrast activators in group III require only phospholipid and 
CaCl2 for the activation of prothrombin. They do not require factor Va, but 
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appear to possess a co-factor that is tightly bound to the catalytic subunit 
that plays a similar role to factor Va in prothrombin activation.40 
 
         Although thrombin has many activities, the ability of some snake 
venom enzymes to clot fibrinogen has resulted in these enzymes being 
called  “thrombin-like”40‚41 .These are widely distributed primarily in the 
venom of snakes from true vipers (Bitis gabonica, Cerastes vipera) and pit 
vipers (Crotalus adamanteus, Bothrops atrox).  Snake venom fibrinogen 
clotting enzymes have been classified into several groups based on the 
rates of release of fibrinopeptides A and B from fibrinogen. 
 
          One mechanism of the anticoagulant action of snake venom proteins 
is attributed to the activation of protein C. Activated protein C degrades 
factors Va and VIIIa and therefore, has anticoagulant activity. Another 
mechanism of anticoagulation involves inhibition of blood coagulation 
factors IX and X by venom protein(s) that binds to either or both.  
 
Finally, anticoagulation is also achieved through the action of snake 
venom phospholipases that degrade phospholipids involved in the 
formation of complexes critical to the activation of the coagulation 
pathway.42 
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           Direct acting fibrinolytic enzymes have been characterized as zinc 
metalloproteinases and are classified as either alpha or beta chain 
fibrinogenases. Snake venom contains a number of platelet active 
components, including those that cause platelet aggregation and those that 
inhibit platelet aggregation.43 
 
         The final coagulation disturbance depends upon the balance among 
the activity of procoagulant and anticoagulant, fibrinolytic and 
fibrinogenolytic components of injected venom. Disseminated 
intravascular coagulation (DIC) is a consistent feature in patients bitten by 
Russell’s viper, E.carinatus, boomslang and pit vipers.44 
 
         The presence of fibrin thrombi in the renal microvasculature and in 
the glomerular capillaries, and the findings of MAHA and 
thrombocytopenia due to DIC results in cortical necrosis.33  
 
Snake venom initiates a chain reaction involving the coagulation, 
fibrinolytic, kinin and complement system. Venom induced alteration lead 
to vascular coagulation and deposition of fibrin thrombi in blood vessels. 
Intraglomerular fibrin deposition of lesser degree causes ATN via a 
temporary hemodynamic alteration. 
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             0.4 mg/kg of Bothrops jararaca venom produced functional and 
morphological changes observed in snake-bite induced AKI.35 There was 
intravascular hemolysis, as shown by significant decrease in hematocrit, an 
increase in plasma LDH levels and free hemoglobin.  
 
Light and electron microscopy showed massive fibrin deposition in 
glomerular capillaries apart from proximal and distal tubular necrosis and 
red blood cell casts in renal tubules. Ischemia related to glomerular 
coagulation and intravascular hemolysis are the most important 
pathogenetic factors causing a decrease in the GFR, although direct venom 
nephrotoxicity could not be excluded.35 
 
    PATHOPHYSIOLOGY OF ACUTE TUBULAR NECROSIS: 
       After nephrotoxic injury to the kidney, an early response is loss of the 
brush border and polarity of the epithelial cell, with mislocation of 
adhesion molecules, Na+, K+-ATPase  and other proteins.54 
 
          With increasing injury, cell death occurs by means of  necrosis or 
apoptosis. Some of  the necrotic debris is released into the lumen, where it 
interacts with luminal proteins and can ultimately result in obstruction. 
Because of  the  mislocation of adhesion molecules, viable epithelial cells 
lift off the basement membrane and are found in the urine.  
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The kidney can respond to injury by initiating a repair process if 
provided sufficient nutrients and  sufficient oxygen delivery and if the 
basement membrane integrity has not been altered irreparably. 
 
        Viable epithelial cells migrate and cover denuded areas of the 
basement membrane. Cells replacing the epithelium may be derived from 
dedifferentiated epithelial cells or from a subpopulation of progenitor cells 
in the tubule. The cells then undergo division and replace lost cells. 
Ultimately the cells differentiate and re-establish the normal polarity of the 
epithelium. 
 
HISTOLOGY: 
 
 Renal histology shows predominantly either acute tubular or cortical 
necrosis. A number of glomerular changes have been described but their 
significance is not known. 
 
 
Acute Tubular Necrosis: 
      Acute tubular necrosis is the predominant lesion in 70-80% of patients 
with AKI.33 On light microscopy, the tubules appear dilated and are lined 
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by flattened epithelium. Severe cases exhibit cell necrosis and 
desquamation of necrotic cells from the basement membrane. Hyaline, 
granular or pigment casts are seen in tubular lumina.  
 
Varying degrees of interstitial edema, hemorrhage and inflammatory 
cell infiltration are present. Biopsies reveal regenerating tubular 
epithelium. Intrarenal blood vessels are usually unaffected. 
 
      On ultrastructural examination, proximal tubules show dense intra 
cytoplasmic bodies representing degenerating organelles or protein 
resorption droplets. Small areas of basement membrane are denuded. 
Distal tubular cells have a dilated endoplasmic reticulum and many 
degenerating organelles. 
 
                Apoptosis is a prominent feature in the distal tubules, indicating 
a high cell turnover. In the interstitium, fibroblasts appear active, with 
increased numbers of organelles and cytoplasmic processes. Mast cells and 
eosinophils show both granulated and partially degranulated form.⁴⁵ 
 
             Ultrastructural abnormalities are notable in both large and small 
caliber vessels.⁴⁵ Medullary vessels are severely affected, with markedly 
swollen, focally necrotic, endothelial cells obliterating the lumen. Smooth 
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muscle cells show cytoplasmic vacuoles, which are empty or filled with 
granular material. 
 
 The severe vascular lesions, distal tubular apoptosis, and presence 
of mast cells, eosinophils, and active fibroblasts in the interstitium  are 
observed in acute tubular necrosis of snake bite induced AKI. 
 
Acute Cortical Necrosis: 
           Bilateral diffuse or patchy cortical necrosis has been observed 
following bites by E.carinatus. Cortical necrosis appears to be more 
common among Indian patients. 
 
           The presence of fibrin thrombi in the arterioles is a prominent 
feature in these patients. A narrow subcapsular rim of cortex often escapes 
necrosis. The area underlying this shows necrosis of glomerular as well as 
tubular elements. The necrotic zone is often bordered by an area of 
hyperemia and leukocytic infiltration.  
Calcification of necrotic areas may occur at a later stage. Varying 
numbers of glomeruli are spared with patchy cortical necrosis. With 
healing, fibroblastic proliferation and organization of thrombi are seen45. 
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           Renal ultrastructure in cortical necrosis following Russell’s viper 
shows glomeruli with collapsed capillary basement membrane, and 
denuded foot processes. No viable endothelial or mesangial cell can be 
identified, but swollen rounded cells, possibly of endothelial origin, are 
seen in some capillary lumina. 
 
Endothelial swelling of small arterioles and necrosis of peritubular 
capillaries are also seen. The tubular basement membrane are intact, but 
the epithelium shows degenerative changes. The urinary space contained 
unidentified cells with large cytoplasmic vacuoles45.  
 
The tubular basement membrane is thickened, and the cortical 
tubules are lined by flattened epithelium, with large nuclei and a dilated 
endoplasmic reticulum. Fibroblastic proliferation is seen in the 
interstitium. 
 
 
 
Glomerular Lesions: 
       "Proliferative glomerulonephritis” are reported in patients bitten by 
E.carinatus and also crescentic glomerulonephritis, following puff adder 
bites, presenting as AKI.26 Renal lesions of proliferative nephritis with 
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crescents has developed within 24-48 hours. Crescentic  
glomerulonephritis are found to occur following  Russell’s viper bite. 
 
           Russell’s viper bite, shows thickening of the mesangial areas and 
mild mesangial proliferation and diffuse glomerular hypercellularity 
(marked mesangial proliferation). Other glomerular  changes are 
ballooning of capillaries, endothelial swelling, mesangiolysis and splitting 
of the glomerular basement membrane.  
 
                Immunofluorescence  microscopy shows IgM, C3 and fibrin 
deposits. Also a diffuse and intense mononuclear cell infiltrate has been 
noted in the interstitium, suggesting the occurence of an acute interstitial 
nephritis.⁴⁶ 
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RIFLE and AKIN criteria for diagnosis of AKI  
RIFLE criteria 
Class GFR Criteria Urine output criteria 
Risk 
Increased S.creatinine x 
1.3 or GFR decrease > 
25% 
Urine output 
< 0.5 ml/kg/h x 6h 
Injury Increased S.creatinine x 2 or GFR decrease > 50% 
Urine output 
< 0.5 ml/kg/h x 12h 
Failure 
Increased S.creatinine x 3 
or GFR decrease > 75% 
or S.creatinine ≥ 4 mg/dl 
(Acute rise of ≥ 0.5 
mg/dl) 
Urine output 
< 0.3 ml/kg/h x 24h of 
Anuria x 12h 
Loss 
Persistent AKI = 
complete loss of renal 
functions > 4 weeks 
 
ESKD End stage kidney disease > 3 months  
 
AKIN classification  
Stage Serum creatinine criteria Urine output criteria 
1. 
Increase in serum creatinine of 
≥ 0.3 mg/dl 
Or increase to ≥ 150 to 200% 
from baseline 
Urine output < 0.5 
ml/kg/h x 6h 
2 
Increase in serum creatinine to 
> 200 to 300% from baseline 
Urine output ≤ 0.5 
ml/kg/h x 12h 
3 
Increase in serum creatinine to 
> 300% from baseline 
Urine output < 0.3 
ml/kg/h or anuria x 12h
27 
 
BIOMARKER: 
                Early detection of renal injury is of key importance to impact 
morbidity and mortality and the introduction of potential therapeutic agents into 
the course of renal disease. 
 
Human NGAL: 
           Human NGAL (synonyms: lipocalin 2, siderocalin, neutrophil lipocalin) 
is 25kDa secretory glycoprotein belongs to lipocalin superfamily⁷. NGAL has 
been orginally isolated from the secretory granules of activated human 
neutrophils.⁴⁶ 
 
           Human NGAL consists of a single disulfide bridged polypeptide chain of 
178 amino acid residues with a calculated molecular mass 22kDa⁴⁶ and its 
glycosylation increases its apparent molecular mass to 25kDa. 
 
            They are small secreted proteins characterized by their ability to bind 
small, hydrophobic molecules in a structurally conserved pocket formed by 8 
antiparallel  beta pleated sheets, it binds to specific cell surface receptors to 
form macromolecular complexes.⁴⁷ 
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               NGAL is a protease resistant polypeptide, released from the distal 
tubules, secreted with the urine or backleaking to the plasma,  freely filtered,  
reabsorbed in the proximal tubules through endocytic megalin receptors or 
finally secreted with the urine.⁴⁸ Because of  its small molecular size, and 
resistant to degradation, NGAL is readily excreted. 
 
 NGAL is responsible for growth and differentiation of renal tubular 
epithelial cells and exerts bacteriostatic effects in the distal urogenital tract by 
interference with bacterial siderophore-mediated iron acquisition. This 
sidreophore iron complex limits proximal tubular damage and reduces 
apoptosis.⁴⁸ 
 
Gene expression studies in AKI have also shown rapid upregulation of 
NGAL mRNA in the thick ascending limb of Henle’s loop and the collecting 
ducts, with resultant synthesis of NGAL protein in the distal nephron (the renal 
pool) and secreted into the urine. 
 
         AKI results in increased NGAL mRNA expression in distant organs, 
especially the liver and spleen, and the over-expressed NGAL protein is most 
likely released into the circulation and constitutes the systemic pool.  
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 Additional contributions to the systemic pool in AKI may derive from 
the fact that NGAL is a known acute phase reactant  and   released from 
neutrophils, macrophages, and other immune cells.51 Any decrease in 
glomerular filtration rate resulting from AKI would be expected to decrease the 
clearance of NGAL, with further accumulation in the systemic pool. These 
factors are responsible for the elevated levels of  NGAL  in the plasma during  
AKI.51  
 
Raised plasma levels of NGAL were found to be strongly correlated with 
decreased renal function in patients with renal damage due to nephrotoxicity.49, 50  
 
          Hence, Plasma NGAL has emerged as a biomarker that predict the 
development of AKI in patients 1-3 days earlier than serum creatinine.50, 51, 52  
 
           NGAL appears to be an early potential ‘real time’ biomarker for AKI and 
its expression is proportional to the severity of renal injury. 
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MATERIALS AND METHODS 
 
Study Design                :   Prospective case control study. 
Place of study               :   Department of Bio chemistry. 
                                           Thanjavur Medical College and Hospital. 
Period of study              :   October 2009 to July 2010. 
Sample size                   :   50 Cases and 50 Controls. 
Sampling procedure      : 
             100 patients admitted for snake bite were followed with estimation of 
NGAL, serum creatinine, blood urea to diagnose AKI.  Patients developed AKI 
were considered as cases. Patients not developed AKI were considered as 
Controls.  
 Inclusion Criteria        :  
                                               Patients admitted within 12 hours of snake bite.   
 Exclusion Criteria        : 
                                         1.  Snake bite  patients with elevated serum 
                                               creatinine on admission. 
                                   2.   Known Hypertensive on treatment. 
                                   3.   Chronic Kidney Disease. 
                                   4.   Known Diabetic on treatment. 
                                   5.   Systemic and Urinary tract infections. 
                                   6.   Past history of renal disease. 
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STUDY PROTOCOL 
History: 
A detailed history was elicited for  
• Co-morbid diseases and concomitant drugs intake. 
• Species of snake. 
• Site and time of bite. 
• Native treatment. 
• Treatment before hospitalization. 
• Hematuria,  hemetemesis,  hemoptysis, bleeding gums and bleeding from 
the site of bite. 
• History of reduced urine output, oliguria and anuria. 
 
CLINICAL EXAMINATION: A thorough physical examination was done to 
look for local and systemic features of envenomation like fang marks, cellulitis, 
bleeding from the site of bite, local necrosis, blistering, gangrene, regional 
lymph node enlargement and features of gum bleeding, epistaxis, ecchymosis. 
        All vital signs were looked for. 
        Features of uremic symptoms were looked for. 
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INVESTIGATIONS: 
1. Complete Blood Count 
2. Bleeding time 
3. Clotting time 
4. Urine Albumin, Sugar, Deposits including pus cells, RBCs. 
5. Random blood sugar done by Glucose Oxidase -Peroxidase Method. 
6. USG Abdomen done to exclude Chronic kidney disease. 
7. Plasma  NGAL 
8. Blood urea and serum creatinine 
9. Serum electrolytes 
 
COLLECTION OF SPECIMENS 
               Blood samples were collected under aseptic precautions in EDTA 
coated polypropylene tubes. Blood was centrifuged and plasma was separated.  
The specimens were freezed at -20°C for storage. 
 
               One part of the blood was transferred to plain tubes and the sample 
was centrifuged and serum separated for the analysis of blood urea, serum 
creatinine, and serum electrolytes. 
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ESTIMATION OF NGAL IN PLASMA: 
METHODOLOGY: 
         Solid phase enzyme linked immunosorbent assay. 
PRINCIPLE: 
           The micro wells are coated with monoclonal antibody against human 
NGAL. Aliquots of calibrators, diluted samples and controls are incubated with 
HRP conjugated NGAL antibody. NGAL bound to antibody, while unbound 
materials are washed off. Upon addition of the chromogen substrate, the HRP 
linked to the bound detection antibody reacts with the substrate to generate a 
colored product. The color intensity is read at 450 nm in an ELISA reader and 
the intensity of the color developed is proportional to the concentration of 
NGAL. 
KIT CONTENTS: 
1. 12 × 8 coated Microwells (96 wells) +Frame 
2. 5 × Sample diluents Conc. (1 × 60 mL ) 
3. NGAL Rapid calibrator 1-6 (6 × 1 mL ) 
4. 25 × Wash solution conc. (1× 30 mL ) 
5. Horse Radish Peroxidase-conjugated NGAL Antibody (1 × 6 mL ) 
6. Tetra Methyl Benzidine (TMB) substrate (1 × 12 mL ) 
7. Stop solution: 0.5 mol / L sulphuric acid (1 × 16 mL ) 
8. Polypropylene U –Microwell Plate 96 wells 
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NGAL Calibrator Concentrations ng/mL 
Calibrator 1 0 
Calibrator 2 0.3 
Calibrator 3 2.2 
Calibrator 4 5.1 
Calibrator 5 10.6 
Calibrator 6 19.2 
 
PREPARATION OF REAGENTS: 
1. All specimens and reagents are brought to room temperature (20-25°C).  
Specimens are mixed thoroughly by gentle inversion and visible 
particulate matter is cleared by low-speed centrifugation. 
2. Wash Solution: 25x Wash Solution Concentrate is diluted by pouring the 
total contents of the bottle (30 ml) into 1-L graduated cylinder and  
deionized water is added to make a final volume of 750 ml. It is 
thoroughly mixed. 
3. Sample Diluent:  5x Sample Diluent Concentrate (contains yellow dye to 
aid pipetting) is diluted  by pouring the total contents of the bottle (60 ml) 
into a 500-ml graduated cylinder and  deionized water is added to make a 
final volume of 300 ml.  It is thoroughly mixed. 
4. NGAL Rapid Calibrators (ready to use): It is not diluted further. 
5. HRP- conjugated NGAL Antibody: It is not diluted further. 
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6. Stop Solution: It is not diluted further. 
7. TMB Substrate: It is not diluted further. 
 
 ASSAY PROCEDURE: 
1.  The appropriate wells for setting up of  calibrators, diluted patients 
specimens and diluted controls are assigned 
2.  Samples are diluted  according to the expected NGAL concentrations, 
1/100 for plasma. 
3.  A sufficient volume of each calibrator, each diluted sample and diluted 
controls are pipette  into the appropriate wells of the polypropylene U-
microwell plate to permit subsequent transfer of 50 µL volumes to 
corresponding coated microwell. 
4.  50 µL volumes of HRP – conjugated NGAL antibody are pipetted into 
the coated microwells. Then with a multichannel pipette,  50 µL volumes 
of calibrator solutions, diluted samples from the U wells are rapidly 
transferred  into the corresponding coated wells already containing the 
detection antibody.  
5.  The wells are covered and incubated  for 30 minutes at room temperature 
on a shaking platform and set at 200 per minute. 
6.  The contents of the microwells are aspirated and washed with 300 µL of 
diluted wash solution to facilitate removal of unbound material. 
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7.  100 µL of TMB substrate are dispensed  into each microwell and 
incubated for 15 minutes at room temperature in the dark. 
8.  100 µL of Stop solution is added to each well and mixed by gentle 
shaking for 20 seconds. The wells are read within 30 minutes. 
9.  The absorbances of the wells are read at 450nm in an ELISA reader. 
 
CALCULATION OF RESULTS: 
Calibration graph: 
        Calibration curve was constructed by plotting the mean of duplicate 
absorbance values for each NGAL Calibrator on the y-axis against the 
corresponding NGAL concentrations in ng/mL on the x-axis. 
NGAL values of subjects: 
         The NGAL concentration of each diluted sample was found by locating 
the point on the curve corresponding to the mean of duplicate absorbance values  
for the diluted samples and reading its corresponding concentrations in ng/mL 
from the x-axis.  
          The concentration of NGAL in diluted specimens was calculated by 
multiplying the result by the sample dilution factor. 
Storage: 
         All reagents are stored at 2-8°C.  
Reference value: 
        33-106 ng/mL. 
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QUANTITATIVE DETERMINATION OF SERUM CREATININE 
[MODIFIED JAFFE’S KINETIC METHOD] 
 PRINCIPLE OF THE METHOD: 
               Creatinine present in the sample reacts with picric acid in alkaline 
medium forming creatinine picrate (red coloured complex) which is measured  
at 500 nm.    
 
REAGENTS: 
Reagent 1 (picrate): 
              Picric acid                          34.9 mmol / L 
              Sodium Hydroxide             45 mmol / L 
Reagent 2 (Sodium Hydroxide):  
               Sodium hydroxide             0.26 mol/L 
Standard (Creatinine 2 mg/dL): 
                Creatinine                         0.020 g/L 
STORAGE:      2ºC-8ºC 
 
PREPARATION OF WORKING SOLUTION: 
           The reagents are allowed to attain room temperature .  Equal volumes of 
reagent 1 & reagent 2 are mixed  in a clean beaker. 
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PROCEDURE: 
       The sample and the working solution  are  brought to room temperature 
prior to use. 
 
GENERAL SYSTEM PARAMETERS: 
Reaction Type                           :        Fixed Time 
Reaction slope                           :        Increasing 
Wavelength                               :        500 nm (490-510 nm) 
Flowcell Temp.                         :        25°C, 30°C or 37°C 
Delay Time                               :         30 seconds. 
No. of Readings                        :        120 seconds. 
Sample Volume                        :         100 µL 
Reagent Volume                       :         1.0 mL 
Pathlength                                 :        1 cm 
Std. Concentration                    :        2 mg/dL 
Zero Setting With                     :        Distilled water 
The instrument is set with using above system parameters.                               
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PROCEDURE: 
            3 test tubes are taken  and labeled  them as blank (B), Standard (S), Test 
(T). 1 ml of working reagent is added to 3 test tubes.  100µL of sample  is added  
to test tube labeled ‘T’ and 100µL of standard is added to test tube labeled ‘S’. 
It is mixed and read  immediately. 
 Blank Standard Test 
    Reagent         1 mL            1 mL        1 mL 
    Standard           --           100 µL           -- 
    Sample           --             --        100µL 
   
LINEARITY:  
        This method is linear upto 10 mg/dL. 
REFERENCE VALUES: 
        Serum Creatinine: 
            Males         : 0.6-1.3 mg/dL 
            Females     : 0.6-1.1 mg/dL 
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QUANTITATIVE ESTIMATION OF UREA BY  UREASE METHOD 
(BERTHELOT’S REACTION): 
 PRINCIPLE: 
       Urease splits urea into ammonia and carbon dioxide. The ammonia reacts 
with phenol in the presence of hypochlorite to form an indophenol which with 
alkali gives a blue coloured compound. The intensity of the colour is 
proportional to the concentration of urea in the sample and is measured at 
546nm.  
 
REAGENTS: 
Reagent 1(Urease): 
Urease       > 1KSU/L 
Reagent 1A (Buffer):                      
Disodium EDTA     0.1 mol/L 
Sodium Nitroprusside    6 mmol/L 
Reagent 2 (Phenol): 
Phenol      1.8 mmol/L 
Reagent 3 (Hypochlorite): 
Sodium hypochlorite   0.47 mol/L 
Standard (Urea 40 mg/dL): 
Urea      0.4 g/L 
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REAGENT RECONSTITUTION 
SOLUTION (1) 
        The contents of one  bottle of reagent 1A is transferred  into one  bottle  of  
reagent 1 and  mixed gently. 
SOLUTION (2) 
 77 mL of distilled water is added into one bottle of reagent  and  mixed gently. 
SOLUTION (3) 
 77 mL of distilled water is added into one bottle of reagent 3and mixed gently. 
PROCEDURE 
The samples and the reconstituted solutions are brought to the room temperature 
prior to use. 
General System Parameters: 
Reaction Type  : Endpoint 
Reaction Slope  : Increasing 
Wavelength   : 546 nm (530 -570 nm) 
Flow cell Temperature : 30 º C 
Incubation   : 10 minutes (1 st step) 
                                                    15 minutes (2 nd step)   at 37 ºC 
Sample Volume  :  10 µL 
Reagent Volume  : 3.1 mL (Reagents 1+2+3) 
Standard Concentration : 40 mg/ dL 
Zero Setting With  : Reagent Blank 
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 The instrument is set using above system parameters. 
PROCEDURE: 
      3 test tubes are taken and labeled them as blank(B),  Standard(S),Test(T). 
100µL of solution 1 is added to 3 test tubes. 10µL of  sample is added to test 
tube labeled ‘T’ and 10µL of standard  is added to test tube labeled ‘S’. 
 Blank Standard Test 
Solution 1 100 µL 100µL 100µL 
Standard - 10 µL - 
Sample - - 10µL 
 
Incubated for 10 minutes at 37°C.It is mixed and then added 
Solution 2 1.5 mL 1.5 mL 1.5 mL 
Solution 3 1.5 mL 1.5 mL 1.5 mL 
 
Incubated for 15 minutes at 37°C.It is mixed and then read. 
LINEARITY 
The method is linear upto 200 mg/dL 
REFERENCE VALUE: 10-50 mg/dL 
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RESULTS AND STATISTICAL ANALYSIS 
 
     Table 1 : Age distribution among control and case 
group 
Age Group 
Control  Case 
No. % No. % 
Upto 30 yrs 12 24 14 28 
31-40 12 24 10 20 
41-50 16 32 16 32 
51 & above 10 20 10 20 
Total 50 100 50 100 
Range 
Mean 
S.D. 
20 - 58 yrs 
39.5 yrs 
11.1 yrs 
20 - 60 yrs 
39 yrs 
11.2 yrs 
‘p’ 
0.8119 
Not Significant 
 
44 
 
 
 
 
 
 
 
 Table 2 : Sex Distribution among control and case 
group 
Sex Control  Case 
No. % No. % 
Male 30 60 33 66 
Female 20 40 17 34 
Total 50 50 50 100 
‘p’ 0.6787 Not  Significant 
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Table 3 : Comparison of NGAL values in the control and 
case group 
NGAL values Control  Case 
Range 14 – 54 38-1020 
Mean 33.9 536.7 
S.D. 9.2 244.7 
‘p’ 0.0001 Significant 
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Table 4 : Comparison of NGAL  values in different age 
groups among control and case group 
 
Age group 
Control  Case 
Mean S.D. Mean S.D. 
Upto 30 yrs 33.0 6.6 497.1 
253.4 
31-40 31.3 11.1 403.5 
243.2 
41-50 38.3 8.2 662 
223.7 
51 & above 30.4 9.3 525.1 201.2 
‘p’ 0.0953 Not significant 
0.0561 
Not significant 
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    Table 5 : Comparison of  NGAL values among males  
   and females in  control and case group 
 
Sex 
Control  Case  
Mean S.D. Mean S.D. 
Male 36.7 9.1 555.7 224.3 
Female 32.6 7.8 500.0 283.8 
‘p’ 0.6671 Not significant 
0.6671 
Not significant 
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Table 6 :Comparison of  Creatinine values in control and 
case group 
 
Creatinine values 
on 
Control  Case 
‘p’ 
Mean S.D. Mean S.D. 
Day 1 0.9 0.14 0.89 0.12 0.6446 Not significant 
Day 2 0.99 0.1 0.98 0.1 0.4983 Not significant 
Day > 3 0.95 0.13 3.12 0.45 0.0001 Significant 
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Table 7 :Comparison of  Urea values in Control and  Case 
Group 
 
Urea values on 
Control  Case  
‘p’ 
Mean S.D. Mean S.D. 
Day 1 35.7 3.7 36.3 3.3 
0.5466 
Not significant 
Day 2 36.3 3.8 37.4 3.0 
0.0724 
Not significant 
Day > 3 34.1 5.6 71.12 17.9 
0.0001 
Significant 
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Table 8 : Comparison of NGAL, with serum creatinine 
and  blood urea on Day 1 
Day 1 Mean S.D ‘p’ 
NGAL Cases Controls 
536.7 
33.9 
244.7 
9.2 0.0001 
Serum 
creatinine 
Cases 
Controls 
0.89 
0.9 
0.12 
0.14 
0.6446 
Not significant 
Blood urea Cases Controls 
36.3 
35.7 
3.3 
3.7 
0.5466 
Not significant 
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Table 9 : Pearson’s Correlation Coefficient between 
NGAL, Creatinine and  Urea 
 
Correlation Coefficent between
 
Correlation 
Coefficient 
 
Correlation 
NGAL & Creatinine on Day 1 0.0494 Not Correlated 
NGAL & Creatinine on Day 2 0.0569 Not Correlated 
NGAL & Creatinine on Day≥ 3 0.5432 Correlated 
NGAL & Urea on Day 1 0.1318 Not Correlated 
NGAL & Urea on Day 2 0.0961 Not Correlated 
NGAL & Urea on Day≥ 3 0.5035 Correlated 
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RESULTS 
 
• Table 1 shows age distribution among case and control subjects. There is 
no significant age differences between the two groups. 
 
• Table 2 shows sex distribution between cases and controls. There  is no 
significant differences between the two groups. 
 
 
• Table 3 shows the plasma levels of  NGAL between cases and controls. 
Plasma NGAL level is significantly higher in cases with  mean of 536.7 
than control group with mean of  33.9. This difference  in the plasma 
NGAL level between cases and control  gives a 'p' value  of  0.0001 
which is highly significant. 
 
• Table 4 shows age matched Plasma NGAL values between cases and 
controls. There is no significant difference in plasma NGAL value in 
different age groups among cases with 'p' value  0.0561 and controls with 
‘p’ value  0.0953. 
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• Table 5 shows the plasma NGAL values among male and female groups 
in cases and controls. There is no significant difference in Plasma NGAL 
values between males and females in cases with 'p' value of 0.6671 and 
controls with 'p' value of 0.6671. 
 
• Table 6 shows serum creatinine values on day 1, day 2, day 3 and above 
between cases and controls. There is no significant change in serum 
creatinine level on day1 and  day 2 between cases and controls. On day 3 
and above serum creatinine is elevated in cases than in controls with 'p'    
value of 0.0001 which is significant. 
 
• Table 7 shows blood urea values on day1, day2, day 3and above between 
cases and controls. Blood urea is not significantly elevated on day1 and 
day2  between cases and controls. On day 3 and above, blood urea is 
elevated in cases than controls with 'p' value of 0.0001.  
 
• Table 8 shows comparison of  NGAL values, serum creatinine and blood 
urea between cases and controls on Day1. There is a significant rise in the 
NGAL levels among cases than controls with ‘p’ value 0.0001. There is 
no significant rise in serum creatinine and blood urea between cases and 
controls. 
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DISCUSSION 
 
 This study evaluates the use of  NGAL for early diagnosis of AKI than 
serum creatinine and blood urea because NGAL raises in plasma even before 
renal cell necrosis occurs after the nephrotoxic insult like snake bite. AKI is an 
important complication of snake bite and a major cause of morbidity and 
mortality in India. 
 
 The traditional laboratory test to diagnose  AKI such as estimation of 
serum creatinine will be detected in serum only after 50% of renal cell death has 
occurred. Serum creatinine does not accurately depict kidney function until a 
steady state has been reached, which requires more than 3 days.1,51 
 
Hence it does not allow for early detection of acute renal injury. Damage 
to renal tubules alone is not sufficient to result in a change in a parameter of 
kidney function such as serum creatinine. 
 
The change in serum creatinine, however, does not discriminate the time 
and type of renal insult or the site and extent of glomerular or tubular injury. 
Levels are relatively insensitive to small changes in GFR and may lag behind 
changes in GFR by several days. 
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 In addition, in cases of more extensive tubular injury, there is a lag in 
time between the injury and an increase in serum creatinine. Sensitive biologic 
markers for renal tubular injury are needed in order to detect early kidney 
injury. 
 
 In the present study, the mean value of Plasma NGAL is 536.7 in the 
case group shows a significant rise than the control group with  the mean of  
33.9 during the initial hours of snake bite with 'p' value 0.0001. 
 
          The values of  plasma NGAL and serum creatinine in cases and controls 
are compared, it shows a  marked  elevation of  plasma NGAL  than serum 
creatinine  during the early hours of snake bite with 'p' value of NGAL  <0.0001 
and 'p' value of serum creatinine 0.6446. 
 
          Those patients who showed elevated NGAL level on initial hours of 
admission with Mean of 244.7 is found to have developed Acute Kidney Injury 
on serial estimation of serum creatinine for 3 days and above. 
  
This study shows the rise in serum creatinine and blood urea are observed 
only on the 3rd day of nephrotoxic insult who developed acute kidney injury. 
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AREA UNDER THE CURVE 
 
 
 
With an area under the curve of 0.992 and a standard error of 0.006, 
NGAL shows an asymptotic significance of 0.000 proving it as a better 
predictor over creatinine, in diagnosing AKI. This suggest utility of NGAL as 
an excellent standalone marker. 
 
This study correlates with the reported AUC in the 0.93-1 range given in 
previous studies53 done by Mishra et al, Benett et al. 
 
Various epidemiological and clinical studies have shown strong 
association between rise in NGAL and early detection of AKI than serum 
creatinine which is delayed by several days. 
 
In the Pearson’s correlation analysis, as shown in table 9, there is a no 
significant correlation noticed between  rise in plasma NGAL  and serum 
Area Std. Errora Asymptotic Sig.b 
Asymptotic 95% Confidence 
Interval 
Lower Bound Upper Bound 
.992 .006 .000 .000 1.000 
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creatinine on the day of admission. Progressive kidney damage leading to  rise 
in serum creatinine shows a significant correlation  between NGAL and 
creatinine on day 3. 
 
Our results clearly indicate that plasma NGAL is a powerful early 
biomarker of AKI that precedes the increase in serum creatinine by 3 days. 
 
Therefore it is necessary to detect acute tubular injury in a timely manner 
with the use of NGAL, so that early intervention can be initiated. 
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CONCLUSION 
 
                This study on snake bite patients shows that plasma NGAL is a 
promising early predictive bio-marker of acute kidney injury than blood urea 
and serum creatinine.  This novel bio- marker might facilitate earlier diagnosis 
of  acute kidney injury and management decision including administration of 
specific preventive and therapeutic strategies, potentially resulting in fewer 
morbidity and mortality. 
 
          This makes NGAL potentially a very sensitive marker of different 
degrees of renal injury. 
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SCOPE FOR FUTURE STUDY 
 
In addition to early diagnosis and prediction, it would be desirable 
to use NGAL capable of predicting clinical outcomes, allowing for risk 
stratification and monitoring response to therapeutic interventions. 
         
 
Master chart        CASES  
 
SL.
No Age Sex 
Types of 
Snake 
Plasma 
 NGAL 
   ng/mL 
Sr. Creatinine 
[mg/dL] 
Blood Urea 
[mg/dL] 
Electrolytes 
mEq/L BT 
mt 
CT 
mt 
Urine 
Examination 
Day 1 Day 2 Day ≥3 Day 1 Day 2 Day ≥3 Na K Alb RBC 
1.      20 M    viper 440 0.8 0.9 2.4 28 30 60 140 4.0 3 10 + Nil 
2.  26 M unknown 483 0.7 0.9 2.3 36 34 57 135 3.8 4 10 + Nil 
3.      29 F viper 107 1.0 1.0 2.9 39 40 61 142 4.2 4 8 + 1-2 
4.      20 F viper 706 0.8 1.0 3.2 33 36 98 145 4.4 3 7 ++ 0-1 
5.  39 M viper 662 1.1 1.1 2.7 39 40 74 138 5.0 4 9 + 2-3 
6.  42 F unknown 702 0.9 0.9 3.8 40 41 106 142 5.0 3 8 ++ 1-2 
7.  40 M viper 685 0.7 1.1 3.7 39 41 57 136 3.8 3 12 ++ 1-2 
8.  44 M viper 107 0.9 1.1 3.4 38 39 60 140 3.6 5 10 + Nil 
9.  47 M viper 717 1.1 1.0 3.2 39 39 63 144 4.0 4 7 + 0-1 
10.  49 M unknown 588 0.8 0.9 3.5 38 40 62 138 4.2 3 9 + 1-2 
11.  42 M viper 708 0.8 1.0 3.7 35 36 104 146 4.8 3 8 ++ 0-1 
12.  54 M viper 470 0.8 0.8 3.4 40 40 74 138 3.8 4 12 + Nil 
13.  43 M viper 637 1.0 1.0 3.9 37 39 53 136 3.5 3 7 + 1-2 
14.  33 F viper 99 0.9 0.9 3.4 34 34 63 142 4.2 3 9 + 2-3 
15.  24 M unknown 476 0.9 1.1 2.2 32 33 53 144 3.8 3 8 + 1-2 
16.  21 M viper 748 0.8 1.0 2.6 38 38 87 148 3.7 4 12 + 2-3 
17.  38 M viper 476 1.0 1.1 2.2 34 36 57 150 4.8 3 7 + 2-3 
18.  33 M viper 126 0.9 0.9 2.9 39 40 50 138 5.0 3 9 + 1-2 
19.  32 F viper 500 1.0 1.0 2.8 35 37 68 142 4.1 4 9 + Nil 
20.  32 F viper 588 0.9 1.0 2.9 35 35 56 141 3.8 3 8 + 1-2 
21.  30 F unknown 621 0.8 0.9 3.0 38 38 72 140 4.1 4 7 ++ 1-2 
22.  33 F viper 520 0.9 0.9 3.2 34 37 63 135 3.8 5 7 ++ 2-3 
23.  31 F viper 110 0.9 1.1 3.1 39 39 75 138 4.0 3 10 + 1-2 
24.  46 F Viper 629 0.8 0.9 3.2 36 39 62 136 4.2 4 8 + Nil 
 
SL.
No Age Sex 
Types of 
Snake 
Plasma 
NGAL 
ng/mL 
Sr. Creatinine 
[mg/dL]
Blood Urea 
[mg/dL] 
Electrolytes 
meq/L BT 
mt 
CT 
mt 
Urine 
Examination 
Day 1 Day 2 Day ≥3 Day 1 Day 2 Day ≥3 Na K A1b RBC 
25.  48 F   Viper 570 1.0 1.0 2.9 35 35 55 148 3.6 3 10 + 1-2 
26.  47 F unknown 532 0.9 0.9 3.5 37 39 54 142 4.0 4 8 ++ Nil 
27.  46 M viper 613 0.9 1.1 2.8 35 36 58 150 3.5 3 7 + 2-3 
28.  43 M viper 527 0.9 1.0 3.0 41 42 76 141 3.9 5 8 + 1-2 
29.  21 M viper 385 1.0 1.1 2.3 34 37 64 144 4.2 3 10 Nil 2-3 
30.  22 M unknown 380 0.8 1.1 3.0 34 34 58 142 4.5 4 11 + 1-2 
31.  30 M viper 515 0.8 0.9 3.2 38 38 51 138 3.8 3 8 ++ 2-3 
32.  24 M viper 444 0.6 0.8 2.6 35 37 82 137 4.0 3 10 + Nil 
33.  37 M unknown 104 0.9 1.1 2.8 36 38 50 143 3.5 3 9 Nil 1-2 
34.  25 M viper 94 0.9 0.9 3.0 40 44 60 148 4.4 4 8 Trace 1-2 
35.  25 F viper 610 0.9 0.9 3.1 28 29 106 141 4.7 3 10 + 2-3 
36.  29 M viper 578 1.0 1.0 2.8 29 32 56 136 3.8 5 12 + 1-2 
37.  46 M viper 710 0.8 1.1 2.8 35 38 102 135 3.6 4 10 + 2-3 
38.  42 M unknown 577 1.0 1.1 3.0 36 39 89 147 4.2 4 8 ++ 1-2 
39.  52 M viper 682 1.1 1.1 3.5 37 37 73 141 4.4 3 8 + 1-2 
40.  60 M viper 629 0.9 0.9 3.4 35 37 84 138 4.7 4 9 Nil 2-3 
41.  42 M viper 802 0.8 1.0 3.5 40 40 57 142 3.6 3 10 + 1-2 
42.  55 M viper 528 1.1 1.1 3.5 32 39 86 137 4.2 4 9 Trace Nil 
43.  47 M viper 625 0.9 0.9    3.1 34 35 103 144 3.9 3 11 + Nil 
44.  54 F unknown 112 0.9 0.9 3.6 38 39 65 140 4.0 3 12 + 1-2 
45.  51 M viper 400 0.7 0.9 3.2 43 35 60 136 4.6 3 7 + 2-3 
46.  45 M viper 650 1.0 1.0 3.8 39 40 57 148 4.2 4 9 + 1-2 
47.  53 M viper 650 0.8 0.8 3.9 40 35 78 141 3.8 4 11 + 2-3 
48.  55 F unknown 114 1.1 1.1 3.9 34 34 93 145 4.1 4 11 Trace Nil 
49.  51 F viper 635 0.9 0.9 3.4 40 41 120 147 4.5 4 9 ++ 1-2 
50.  52 F unknown 544 0.8 0.8 2.9 33 37 82 138 4.3 3 8 + 1-2 
 
CONTROL 
SL.
No Age Sex 
Types of 
Snake 
 
 Plasma
NGAL 
ng/mL 
Sr. Creatinine 
[mg/dL] 
Blood Urea 
[mg/dL] 
Electrolytes 
meq/L BT 
mt 
CT 
mt 
Urine 
Examination 
Day 1 Day 2 Day ≥3 Day 1 Day 2 Day ≥3 Na K A1b RBC 
1.  23 M unknown 42 0.9 1.1 0.9 33 33 30 143 3.8 4 6 Nil    Nil 
2.  34 M unknown 9 1 1.1 1.1 40 41 35 138 4.0 6 7 Nil    Nil 
3.  37 M unknown 14 1.1 1.1 1.1 37 37 28 136 3.5 3 6 Nil Nil 
4.  34 F unknown 18 0.6 0.8 0.8     36 36 25 147 4.2 6 6 Nil Nil 
5.  47 F unknown 38 1.1 1 1.1 34 34 38 141 4.7 8 6 Nil Nil 
6.  45 M unknown 14 0.9 1 1 35 35 36 138 3.7 5 7 Nil 0-1 
7.  40 M unknown 54 0.7 0.9 0.9 36 36 32 142 4.4 4 8 Nil Nil 
8.  29 2 unknown 28 1 1 1 28 29 36 140 4.7 3 6 Nil Nil 
9.  60 M unknown 30 0.9 1.1 1.1 34 34 42 148 4.5 3 7 Nil Nil 
10.  20 M unknown 33 0.8 1 0.8 32 32 25 142 3.7 4 7 Nil Nil 
11.  23    M unknown 36 0.7 0.9 0.8 29 28 26 138 4.7 6 6 Nil Nil 
12.  21 F unknown 39 0.9 1 0.9 34 35 29 137 3.5 7 9 Trace Nil 
13.  31 M unknown 42 0.9 1 1 35 35 38 148 3.3 8 8 Nil Nil 
14.  30 M unknown 35 0.9 1 0.9 38 38 34 145 4.2 5 7 Nil    Nil 
15.  32 F unknown 19 0.8 1 0.8 34 35 32 137 4.4 4 6 + Nil 
16.  33 F unknown 33 1.1 1.1 1.1 40 40 36 141 4.0 4 7 Nil Nil 
17.  30 F unknown 26 0.9 0.9 1.0 37 38 23 138 3.5 5 6 Nil Nil 
18.  37 F unknown 15 1.1 1.1 1.1 38 38 33 140 3.7 3 8 Nil Nil 
19.  44 F unknown 23 0.7 0.7 0.7 37 37 26 142 4.2 7 8 Nil 0-1 
20.  46 F viper 37 0.6 0.8 0.7 39 40 27 136 3.8   6 7 Nil Nil 
21.  51 M unknown 48 0.8 0.8 0.8 32 32 42 147 4.0 8 6 Nil 1-2 
22.  44 M unknown 24 0.9 1.0 0.9 39 40 46 136 4.2 7 7 Nil Nil 
23.  45 M unknown 44 1.0 1.1 1.0 40 40 38 141 3.8 5 8 Nil Nil 
24.  49 M unknown 32 0.8 0.9 0.9 37 37 34 142 3.7 6 9 Nil Nil 
25.  43 F unknown 24 1.1 1.0 1.1 40 40 32 140 4.5 7 9 Nil Nil 
 SL.
No Age Sex 
Types of 
Snake 
Plasma 
 NGAL 
ng/mL 
Sr.Creatinine 
[mg/dL] 
Blood Urea 
[mg/dL] Electrolytes BT CT 
Urine 
Examination 
Day 1 Day 2 Day ≥3 Day 1 Day 2 Day ≥3 Na K A16 RBC 
26.  57 M unknown 19 1 1 1.1 33 33 38 135 3.8 6 8 Nil 0-1 
27.  52 M unknown 35 1.0 1.0 0.9 39 39 38 137 4.2 7 7 Trace Nil 
28.  25 M unknown 29 1 1 1.1 28 29 36 139 4.0 5 8 Nil 0-1 
29.  23 M viper 32 0.8 1.0 1.0 34 34 40 132 3.8   6 8 Nil Nil 
30.  35 M unknown 38 0.8 1.1 0.8 33 33 23 138 4.0 7 7 Nil 0-1 
31.  26 M unknown 12 0.7 0.9 0.7 36 36 34 141 4.2 8 9 Nil Nil 
32.  42 F unknown 24 0.9 0.9 0.9 35 35 32 136 3.3 9 7    Nil Nil 
33.  41 M unknown 38 1.0 1.1 1.1 36 36 36 130 4.7 6 7 Nil Nil 
34.  44 F unknown 37 1.1 1.1 1.1 41 41 25 147 4.0 7 7 Nil 0-1 
35.  40 M unknown 54 0.7 0.9 0.9 36 36 37 141 3.5 7 8 Nil 0-1 
36.  50 M unknown 52 0.9 0.9 1.0 40 40 37 145 4.0 8 9 Nil Nil 
37.  22 M unknown 16 0.9 1.1 0.8 39 39 24 134 4.1 9 6 Nil Nil 
38.  27 F unknown 20 0.7 0.9 0.8 32 33 32 137 3.8 9 7 Nil Nil 
39.  31 M unknown 24 0.9 1.0 0.8 38 38 38 144 3.7 7 7 Nil 0-1 
40.  33 M unknown 17 1.0 1.1 1.1 34 34 36 142 4.0 8 7 Nil Nil 
41.  48 M unknown 47 1.0 1.1 1.0 38 38 38 138 4.5 8 8    Nil Nil 
42.  35 F viper 24 0.8 1.0 0.9 41 41 36 137 3.8 8 9 Nil 0-1 
43.  43 M unknown 19 0.8 0.9 0.8 41 42 36 141 4.8 5 6 Nil Nil 
44.  41 M unknown 26 1.1 1.1 1.1 39 39 36 147 5.0 4 7 Nil Nil 
45.  53 M unknown 23 0.7 0.9 0.8 28 28 29 145 4.5 5 9 Nil Nil 
46.  55 F unknown 22 1.0 1.1 1.0 28 28 27 144 3.8 4 9 Nil Nil 
47.  54 F unknown 18 0.9 1.0 0.9 35 35 42 147 4.0 5 6 Nil Nil 
48.  58 F unknown 17 0.9 1.0 0.9 32 32 38 138 4.4 3 7 Nil Nil 
49.  51 F unknown 34 0.8 0.8 1.0 40 40 33 147 4.3 7 8 Nil Nil 
50.  47 F unknown 29 1.2 1.1 1.2 37 37 36 143 4.8 5 8 Nil Nil 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                                                                                                                                              
PROFORMA 
Name  : 
Age/Sex  : 
IP No   : 
Occupation  : 
Type of Snake :   Time Lapse after snake bite: 
History 
Swelling of bitten area:   Pain and bleeding from bite site: 
Hematuria:     Bleeding Gums: 
          Oliguria/Non Oliguria:   Breathlessness: 
Clinical Examination: 
Local:      Vital signs 
Cellulitis                PR 
Skin Changes     BP 
Tenderness               RR 
Lymph Node 
 
Systemic Examination: 
RS :                                                          CVS 
ABD                                                         CNS 
Investigations: 
CBC: 
PS 
BT, CT 
Urine Analysis 
Blood Sugar: 
Serum Electrolytes:  
Plasma NGAL: 
 DAY 1 DAY 2 DAY≥3 
UREA   
 
CREATININE   
 
 
USG ABDOMEN: 
AGE DISTRIBUTION
10 10
80%
90%
100%
12
16
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16
30%
40%
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12 14
0%
10%
20%
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GROUP
30 31 40 41 0 1 & A OUpto  years -  years -5  years 5   B VE
SEX DISTRIBUTION
20 17
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MALE FEMALE
NGAL VALUES
536.7
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0
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CREATININE VALUES ON 
DAY 1,2 AND > 3
3.12
4
0.99 0.98
2
3
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0
1
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3&
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CONTROL GROUP STUDY GROUP
UREA VALUES ON 
DAY 1,2 AND > 3
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60
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34.1
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0
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SNAKE VENOM AND THE COAGULATION PATHWAY 
 
 
 
Source:Fauci AS, Kasper DL, Braunwald E, Hauser SL, Longo DL, Jameson JL, Loscalzo JL 
Harrison’s Principles of Internal Medicine, 17th Edition :http://www.accessmedicine.com 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STRUCTURE OF NGAL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ROC curve of NGAL 
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